the latest digital currency news- Top See results about

Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.Institution: The sinking trend of the domestic market is remarkable. The Report on Career Development of Domestic Servants released in 58 shows that in 2024, the demand for nursing old nannies will increase by 21% year-on-year, the demand for raising children will increase by 23%, and the demand for high-end domestic services such as elite housekeepers and children's growth companions will increase by 34%. In addition, the sinking trend of domestic training is obvious, and the number of participants in second-tier and below cities has increased by 229% year-on-year.

Market News: Austria provides 1,000 euros to Syrian refugees to help them return home.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.The grain output of Inner Mongolia exceeded 80 billion Jin for the first time. The reporter learned from the Agriculture and Animal Husbandry Department of Inner Mongolia Autonomous Region on December 13th that according to the latest data released by the National Bureau of Statistics, the grain output of Inner Mongolia exceeded 80 billion Jin for the first time this year, reaching 82.01 billion Jin, achieving a bumper harvest for 21 consecutive years. (Xinhua News Agency)

During the battle of AI glasses, several new financings were under way in the field of AI glasses, among which Viture, which focuses on AR game scenes, and Even Realities, whose current product form is mainly a combination of AI and AR, have entered the late stage of the transaction, and their latest valuations both exceed 100 million US dollars. It is understood that Wang Huiwen, co-founder of Meituan, also recently invested in Viture. The old shareholders of this company founded in 2021 include Lanchi Venture Capital, BAI Capital and Zhenzhi Venture Capital. (latepost)Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.Canada recorded a monthly wholesale sales rate of 1% in October, the largest increase since April 2024. Canada recorded a monthly wholesale sales rate of 1% in October, with an expected 0.5% and a previous value of 0.80%. Canada's annual wholesale sales rate in October was 1.7%, and the previous value was -0.4%. Canada's annual wholesale inventory rate in October was -1%, and the previous value was 0.7%. The monthly rate of wholesale inventory in Canada in October was 0.9%, and the previous value was 0.2%. The monthly inventory rate of manufacturing industry in Canada in October was 0.2%, and the previous value was -0.4%. The monthly rate of new manufacturing orders in Canada in October was -0.9%, and the previous value was 3.9%. The monthly rate of unfinished orders in Canada's manufacturing industry in October was -0.2%, and the previous value was 1.6%. Canada's capacity utilization rate in the third quarter was 79.3%, with an expected 78.9% and a previous value of 79.10%. Canada's manufacturing inventory shipment ratio in October was 1.69%, and the previous value was 1.74%.